Yeow, W-S <br/><br/>
Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01.  [electronic resource] 

 -  British journal of cancer  May 2006 
 - 1436-45 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6603132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticonvulsants--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Histone Deacetylase Inhibitors<br/>Humans<br/>NF-kappa B--genetics<br/>Neoplasms--drug therapy<br/>Staurosporine--analogs & derivatives<br/>Tumor Cells, Cultured<br/>Valproic Acid--pharmacology